Recombinant human papillomavirus type 6/11/16/18/31/33/45/52/58 nine-valent vaccine (Xiamen Innovax Biotech)

重组人乳头瘤病毒6/11/16/18/31/33/45/52/58型九价疫苗（厦门万泰沧海生物）

Report date: 2025/11/20 15:07:35

Base Information

Drug NameRecombinant human papillomavirus type 6/11/16/18/31/33/45/52/58 nine-valent vaccine (Xiamen Innovax Biotech)
Drug Alias Name九价人乳头瘤病毒疫苗（大肠埃希菌）Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58) Vaccine (Escherichia coli)馨可宁 9馨可宁9（Cecolin 9）
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPenile NeoplasmsUterine Cervical NeoplasmsAnus Neoplasms +[6] 
Global Approved IndicationsPapillomavirus Infections
Approved Indications in ChinaPapillomavirus Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2025/05/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesXiamen Innovax Biotech Co LtdBeijing Wantai Biological Pharmacy Enterprise Co LtdXiamen University
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesXiamen Innovax Biotech Co LtdXiamen UniversityBeijing Wantai Biological Pharmacy Enterprise Co Ltd
Inactive CompaniesN/A
Active IndicationsPenile NeoplasmsUterine Cervical NeoplasmsAnus Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A